Abstract. Matrix metalloproteinases (MMPs), also called matrixins, function in the extracellular environment of cells and degrade both matrix and non-matrix proteins. They are multi-domain proteins and their activities are regulated by tissue inhibitors of metalloproteinases (TIMPs).
What does MMP-9 do?
Matrix metalloproteinase (MMP)-9, one of the most widely investigated MMPs, regulates pathological remodeling processes that involve inflammation and fibrosis in cardiovascular disease. MMP-9 directly degrades extracellular matrix (ECM) proteins and activates cytokines and chemokines to regulate tissue remodeling.
What does MMP 13 do?
Matrix metalloproteinase (MMP) 13 is a major enzyme that targets cartilage for degradation. It not only targets type II collagen in cartilage for degradation, but also degrades proteoglycan, types IV and type IX collagen, osteonectin and perlecan in cartilage [4].
How are MMPs activated?
The MMP activation by reactive oxygen is driven through preferential oxidation of the thiol–zinc interaction and autocatalytic cleavage, followed by enzyme inactivation with extended exposure by modification of amino acids critical for catalytic activity, as shown in vitro for MMP-7 [30].
Where are metalloproteinases found?
pleural cavity
Metalloproteinases (MMPs) are a group of proteolytic enzymes which are normally present in the pleural cavity and are frequently overexpressed in malignant tumors (Eickelberg et al., 1997).
What is the normal range for MMP-9?
The normal range of plasma MMP-9 concentration was determined to be 11.4–59.4 ng/ml. We determined the normal range of plasma MMP-9 concentration as 11.4–59.4 ng/ml (mean in 132 controls ± 2 SD).
How do you treat neuropathy in your feet?
Treatment for peripheral neuropathy depends on the cause. Some common treatments involve physical therapy, surgery, and injections for increased nerve pressure. Other treatments focus on reducing pain and discomfort with over-the-counter painkillers such as ibuprofen or aspirin.
Does MMP-13 help neuropathy?
The involvement of MMP-13 in both neuropathies and its conservation in mice indicates that the mechanism may be conserved among sensory neuropathies and translate into humans. Therefore, selective MMP-13 inhibitor applications to the epidermis may be a valuable treatment option for diabetic neuropathy.
Are MMPs growth factors?
MMPs modulate growth factor functions. CTGF induces secretion of ECM proteins by fibroblasts and associates with VEGF to form a VEGF latency complex. Other proangiogenic growth factors can be stored in a latent state through interactions with ECM components.
